Literature DB >> 8620733

Reduction pneumoplasty for giant bullous emphysema. Implications for surgical treatment of nonbullous emphysema.

G L Snider1.   

Abstract

A review of the literature on reduction pneumoplasty for giant bullous emphysema was undertaken to identify current criteria for this surgical treatment and in the hope of obtaining insights into evaluating reduction pneumoplasty for nonbullous emphysema. Twenty-two retrospective case series, published since 1950, were retrieved by a computer search of the literature and a search of the Index Medicus prior to 1966. Reduction pneumoplasty is most effective when bullae are larger than one third of a hemithorax with evidence of compression of adjacent lung tissue and an FEV1 of less than 50% predicted; the presence of emphysema in nonbullous lung and the amount of compression are best judged by CT. The rationale for reduction pneumoplasty for nonbullous emphysema is supported by the similar early functional changes after reduction pneumoplasty for bullous and nonbullous-improvement of blood gas values and lung mechanics. A single study showing that decline of lung function after surgery for bullous emphysema was less in those who stopped smoking than in those who continued to smoke supports the need for preoperative and maintained smoking cessation in patients receiving reduction pneumoplasty. After 4 decades, the duration of improvement in lung function, whether worsening of emphysema occurs in remaining lung, and late morbidity and mortality after reduction pneumoplasty for bullous emphysema are not well defined. A registry with an unoperated-on comparison group could more rapidly accumulate such data after reduction pneumoplasty for nonbullous emphysema.

Entities:  

Mesh:

Year:  1996        PMID: 8620733     DOI: 10.1378/chest.109.2.540

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  12 in total

Review 1.  Lung volume reduction surgery (LVRS) for chronic obstructive pulmonary disease (COPD) with underlying severe emphysema.

Authors:  J Young; A Fry-Smith; C Hyde
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

Review 2.  Lung volume reduction surgery in chronic obstructive pulmonary disease.

Authors:  L Davies; P M Calverley
Journal:  Thorax       Date:  1996-08       Impact factor: 9.139

3.  Video-assisted thoracoscopic surgery in the treatment of patients with bullous emphysema.

Authors:  Kuan-Chun Lin; Shi-Ping Luh
Journal:  Int J Gen Med       Date:  2010-08-30

Review 4.  Chronic obstructive pulmonary disease (COPD) evidentiary framework.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2012-03-01

Review 5.  Surgical and bronchoscopic lung volume reduction in chronic obstructive pulmonary disease.

Authors:  Manoj Meena; Ramakant Dixit; Mrityunjaya Singh; Jai Kumar Samaria; Surendra Kumar
Journal:  Pulm Med       Date:  2014-12-30

6.  Characteristics of COPD phenotypes classified according to the findings of HRCT and spirometric indices and its correlation to clinical characteristics.

Authors:  Ravi Bhaskar; Seema Singh; Pooja Singh
Journal:  Afr Health Sci       Date:  2018-03       Impact factor: 0.927

7.  Chartis System Corrected a Misjudged Location of a Giant Bulla Facilitating a Successful Bronchoscopic Bullectomy with Valves: A Case Report.

Authors:  Fangfang Guo; Yan Hu; Jianxing Qiu; Guangfa Wang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-03-26

8.  Thoracoscopic giant lung bullaectomy: our initial experience.

Authors:  Marina Kolodii; Sharbel Azzam; Michael Peer
Journal:  J Cardiothorac Surg       Date:  2022-03-15       Impact factor: 1.637

9.  Vanishing Lung Syndrome in a Patient with HIV Infection and Heavy Marijuana Use.

Authors:  Basheer Tashtoush; Fernando Gonzalez-Ibarra; Roya Memarpour; Anas Hadeh; Laurence Smolley
Journal:  Case Rep Pulmonol       Date:  2014-01-08

10.  Correlation between clinical characteristics, spirometric indices and high resolution computed tomography findings in patients of chronic obstructive pulmonary disease.

Authors:  Anubhuti Singh; Santosh Kumar; Ashwini Kumar Mishra; Manoj Kumar; Surya Kant; S K Verma; R A S Kushwaha; Rajiv Garg
Journal:  Lung India       Date:  2016 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.